Recent Headlines
Hyperion Biotechnology's Legionella Water Testing Services Can Help Businesses Reopen Safely
Coronavirus is not the only concern for business owners as they reopen. Another threat to health safety is water-borne bacteria called Legionella. - July 17, 2020 - Hyperion Biotechnology, Inc.
Crytur Opens a US Branch
CRYTUR spol s.r.o. announces the opening of a US branch in Boston, MA to provide enhanced support to a rapidly expanding field of North American customers. The US company, Crytur USA, will offer the same high quality products, services and technical support as their customers came to expect from... - July 11, 2020 - Crytur USA
GI Associates of St. Augustine Joins Borland Groover
Merger expands Borland Groover's gastrointestinal health capabilities and presence in Northeast Florida. - July 11, 2020 - Borland Groover
Robert Oblon, a World Renown Thought Leader in the Conversation Between Physical Health and Mental Happiness, Launches HAPInss Brands Nutritional Science Systems
AmpLifei International, through its eCommerce Platform, is the exclusive marketing and distribution partner of HAPInss Brands exclusive and proprietary line of products. - July 10, 2020 - AmpLIFEi International
40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI
Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from Cayman’s Women in Research program this year. - July 01, 2020 - Cayman Chemical Company
On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene
The ALS Therapy Development Institute (ALS TDI) is excited to announce that on Thursday, June 25, they will be hosting the second episode of their new “How I Brewed This: Craft Brewer Series,” featuring Kevin Smith of Bale Breaker Brewing Company and Mike Smith of B.T. Loftus... - June 20, 2020 - ALS Therapy Development Institute
Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance
Organizations create partnership to support the needs of people living with hemoglobin disorders. - June 11, 2020 - Hemanext
Bio Bench is Cooperating with Helixar Biosciences for the Europe and US Market
Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development. - June 09, 2020 - Bio Bench
Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC
Kaycha Labs Appoints New Chief Marketing Officer to Support Rapid Growth
Kaycha Labs, LLC, the nationwide leader in cannabis and hemp testing, announced today the appointment of Andrew Varga as Chief Marketing Officer. Mr. Varga, a marketing veteran of over 30 years has led marketing initiatives for companies such as Brown Forman Corporation, Papa John’s Pizza and... - May 30, 2020 - Kaycha Labs
Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Kaycha Labs Named First Designated Laboratory for Florida’s Hemp Program
Florida Department of Agriculture and Consumer Services Approves Kaycha Labs for their USDA Approved Hemp Program - May 20, 2020 - Kaycha Labs
Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
Minus K Technology Releases Its New CT-2 Ultra-Thin, Low-Frequency Passive Vibration Isolator
Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.
Fast Track MHRA Approval for Vicore Pharma’s COVID-19 Clinical Trial Received in Record Time
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection. - May 04, 2020 - Orphan Reach
ALS TDI Hosts “Gamers vs. ALS” Virtual Livestream Event to Benefit Critical ALS Research
Gamers can join the livestream video game event on Tiltify, May 3-9, to raise funds for cutting-edge ALS research at the ALS Therapy Development Institute. - May 03, 2020 - ALS Therapy Development Institute
Neurology Associates Offers Video Appointments Throughout Arizona, Out of State
Relaxed Regulations Amid COVID-19 Make Extended Reach Possible - May 02, 2020 - Neurology Associates
New COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing - April 30, 2020 - Life Science Strategy Group, LLC
My-State Trek Virtual Event Provides New Opportunity to Support ALS Research While Social Distancing
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020 - ALS Therapy Development Institute
New Digital App Set to Transform the Landscape of Contact Tracing Practices
In the wake of the COVID-19 epidemic, UK company, Vestigo has launched a new website to promote its efforts to develop a digital tracing app called Dot2Dot and test the prototype within the next few weeks. Dot2Dot will digitise the manual contact tracing procedures utilised by health... - April 17, 2020 - Vestigo
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
HealthWare Systems Earns Better Business Bureau Accreditation
HealthWare Systems has earned its Better Business Bureau Accreditation. The revenue cycle management company is now a BBB Accredited Business. - March 20, 2020 - HealthWare Systems
Rare Diseases Research Funded by $220,000 in Grants from CABRI
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching... - March 12, 2020 - Cayman Chemical Company
Epitope Diagnostics Has Proudly Introduced Immunoassay Kits Exclusively for the Qualitative Detection of COVID-19
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
Clinical Guidelines for Physical Therapy in Huntington Disease
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group
The Cardiac & Vascular Institute First in Florida to Enroll Patients in New Clinical Trial Studying LimFlow Therapy
The Cardiac & Vascular Institute (TCAVI) announced it is the first in Florida to perform a successful procedure in the PROMISE II pivotal study of the LimFlow Percutaneous Deep Vein Arterialization System for the treatment of “no option” Chronic Limb-Threatening Ischemia, a severe... - February 20, 2020 - The Cardiac & Vascular Institute
ASAlaser: Internationalisation and Sustainability Are the 2019 Cornerstones
The evaluation of new markets in which to expand and the retention of existing ones are the mainstay of the year which has just closed for the company, which has recorded a considerable growth in the Far East, Europe, Central and South America. The "Customer Satisfaction 2019" results are certainly noteworthy. Training remains the cornerstone of the activity, with more than 200 training sessions for Human and Vet distributors from over 90 countries and 1400 hours for company staff. - February 06, 2020 - ASA srl
The Pediatric Cancer Research Foundation Funds 6 New Research Grants in 2020
The Pediatric Cancer Research Foundation (PCRF) is proud to award 6 new grants with a total of 18 grants in 2020. These new grants are comprised of three Basic Science, one Translational and three Emerging Research grants totaling $675,000. With these new additions, PCRF will fund over $2.2 million... - January 25, 2020 - Pediatric Cancer Research Foundation
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
North County Health Services Host's 2020 Passion for Healing Gala
North County Health Services (NCHS) will host its 3rd annual gala on April 4, 2020. The Passion for Healing “Roaring into the 20s” Gala will take place at the beautiful Westin Carlsbad Resort & Spa. The event will feature a Roaring Twenties theme. Guests will be transported to... - January 13, 2020 - NCHS
New NF-kB Panel of Antibodies from AbboMax and Human Diseases
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
Three American Association for Anatomy Members Named AAAS Fellows
Three distinguished members of the American Association for Anatomy (AAA) have been elected by their American Association for the Advancement of Science (AAAS) peers to the 2019 Class of AAAS Fellows in three different sections. They are Drs. Rick Sumner (Medical Sciences), Lynne Opperman (Dentistry and Oral Health Sciences), and David Ornitz (Biological Sciences). - December 20, 2019 - American Association for Anatomy
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019 - ALS Therapy Development Institute
HealthWare Systems Launches Updated Website
HealthWare Systems Launches Updated Website: Announcing updates to the revenue cycle management technology website, www.healthwaresystems.com. - December 13, 2019 - HealthWare Systems
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019 - ALS Therapy Development Institute
Neurology Associates Neuroscience Center Recruiting Additional Neurologists
Neurology Associates Neuroscience Center is hiring more board-certified neurologists to accommodate its increasing patient load. To date, Neurology Associates employs six neurologists, several of whom specialize in areas including movement disorders, multiple sclerosis, epilepsy, and other... - December 08, 2019 - Neurology Associates
The ASAcampus Team Takes Part in XENOGRISS, One of the Italian Experiments by the Italian Space Agency, for the ESA Beyond Mission
The Space-X 19 was launched at 12:29 EST on December 5 last; on-board it carries some scientific experiments that will be undertaken on the International Space Station during the Beyond Mission, led by the Italian astronaut Luca Parmitano from the European Space Agency. - December 08, 2019 - ASA srl
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Red Pill CBD CEO Says He Was Pleased to Get a Warning Letter from the FDA
On November 25, 2019, the FDA posted on their site 15 companies that received warning letters for illegally selling products containing cannabidiol (CBD), Red Pill Medical, Inc. was one of them. “I know it may sound crazy, but I was pleased with the FDA warning letter,” said Gregory A. - November 28, 2019 - Red Pill Medical, Inc.
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
ASA: Honourable Mention at the C2A Award
The company from Veneto receives an award at the Creative Communication Award programme in Los Angeles for its campaigns dedicated to the HIRO TT and MiS devices. The award conferred for “Brand identity” is the result of the collaboration with Studio D’Orsi. - November 27, 2019 - ASA srl
Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
Compliance Resources from Nationwide Testing Association, Inc.
Nationwide Testing Association, Inc. recently launched a new resource center online. The resource center is aimed at keeping clients up-to-date on all things compliance. In Nationwide Testing Association, Inc.'s resource center, you will find training videos, and news releases on current industry topics. - November 05, 2019 - Nationwide Testing Association Inc.
ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
Cayman Awarded 1.5 Million Dollar SBIR Grant
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company